Hip dysplasia in dogs is a developmental disease that leads to joint instability, progressive cartilage degradation and painful degenerative changes. It most commonly affects large breeds (e.g. German Shepherds, Labradors, Golden Retrievers), but can also occur in other animals. The condition is chronic and requires a comprehensive diagnostic and therapeutic approach.
Treatment of dysplasia includes anti-inflammatory drug therapy, weight control, physiotherapy, cartilage-supporting supplements, and surgery (e.g., pelvic osteotomy, hip replacement). These methods alleviate symptoms and stabilise the joint, but do not restore the natural structure of the cartilage.
MSCs have the ability to differentiate into chondrocytes (i.e. cells that form cartilage) and rebuild cartilage. They are particularly valuable in hip dysplasia because they slow down the degenerative process, improve stability and reduce pain symptoms. They can be used alone or as a supplement to reconstructive surgery.
👉Check out how mesenchymal stem cells work
In the early stages of dysplasia, the use of PRP supports the hip joint environment. Thanks to the growth factors contained in platelets, inflammation can be reduced, pain alleviated and range of motion improved.
👉 Learn more about PRP
In advanced dysplasia, when significant joint destruction has already occurred, IL-1 therapy helps to reduce chronic inflammation and alleviate pain, improving the dog's quality of life.
👉 Learn more about IL-1 pain therapy and treatment
Stage 1 – early symptoms: PRP to reduce inflammation and pain.
Stage 2 – progressive phase: MSC to rebuild cartilage and improve joint stability.
Stage 3 – advanced phase: IL-1 and/or surgery in combination with biological therapies.
Hip dysplasia in dogs is a chronic disease that requires an individual approach. Early diagnosis and the use of biological therapies – PRP, MSC, IL-1 – can significantly improve a dog's quality of life, reduce pain and slow down the progression of the disease.
No, it is a chronic disease, but with appropriate therapies it can be controlled and slowed down, especially with the use of MSCs that rebuild joint cartilage. It is important to start therapy before the joint is severely degenerated in order to restore its function.
Yes, especially in the early stages of the disease, to reduce the risk of rapid development of degenerative changes and effectively rebuild joint cartilage.
Usually several to several months, depending on the severity of the disease and the dog's lifestyle.
Not always – in many cases, biological therapies can delay or reduce the need for surgery.
